HCV prevalence and crude and adjusted OR (patients vs controls) by degree of severity of B-NHL
. | Total . | No. HCV+ . | %HCV+ . | Crude OR (95% CI) . | Adjusted OR (95% CI) . |
|---|---|---|---|---|---|
| Controls | 396 | 22 | 5.6 | 1 | 1 |
| Indolent B-NHL | 170 | 27 | 15.9 | 3.2 (1.8-5.8) | 2.3 (1.3-4.4) |
| Aggressive B-NHL | 230 | 43 | 18.7 | 3.9 (2.3-6.7) | 3.5 (2.0-6.3) |
| Patients with all types B-NHL | 400 | 70 | 17.5 | 3.6 (2.2-6.0) | 3.1 (1.8-5.2) |
. | Total . | No. HCV+ . | %HCV+ . | Crude OR (95% CI) . | Adjusted OR (95% CI) . |
|---|---|---|---|---|---|
| Controls | 396 | 22 | 5.6 | 1 | 1 |
| Indolent B-NHL | 170 | 27 | 15.9 | 3.2 (1.8-5.8) | 2.3 (1.3-4.4) |
| Aggressive B-NHL | 230 | 43 | 18.7 | 3.9 (2.3-6.7) | 3.5 (2.0-6.3) |
| Patients with all types B-NHL | 400 | 70 | 17.5 | 3.6 (2.2-6.0) | 3.1 (1.8-5.2) |
OR was adjusted by age (continuous), sex, level of education, and place of birth